SECOND NEOPLASMS IN DIAGNOSTIC PATIENTS OF POLYCYTHEMIA VERA (PV) OR MIELOFIBROSIS (MF) TREATED WITH RUXOLITINIB

被引：0
|
作者：
Sagues Serrano, M. [1 ]
Osca Gelis, G. [2 ]
Lopez Brunso, M. [3 ]
Gonzalez Montes, Y. [1 ]
Buch Villa, J. [1 ]
Diaz Santa, J. [1 ]
Coll Jorda, R. [1 ]
Cruz Garcia, D. [1 ]
Carvajal Nazly, Santos Y. [1 ]
Lloveras Guelque, N. [1 ]
Kelleher, N. [1 ]
Roncero Vidal, J. M. [1 ]
Blanco Blanco, A. B. [1 ]
Mostacedo Marasovic, S. Z. [1 ]
Bustins Tarrats, A. [1 ]
Serrando Querol, M. [4 ]
Jimenez Romero, O. [4 ]
Tuset Andujar, E. [1 ]
Gallardo Giralt, D. [1 ]
机构：
[1] Hosp Univ Girona Dr Josep Trueta, Serv Hematol, ICO Girona, Girona, Spain
[2] Univ Girona, Fac Ciencies Econ & Empresarials, Hosp Univ Girona Dr Josep Trueta, ICO Girona, Girona, Spain
[3] Hosp Univ Girona Dr Josep Trueta, Serv Farm Hosp, ICO Girona, Girona, Spain
[4] Inst Catala Salut, Lab Clin Area Terr Girona, Girona, Spain
来源：
HAEMATOLOGICA | 2019年 / 104卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
PO-196
引用
收藏
页码：310 / 311
页数：2
相关论文
共 50 条
  • [41] RESPONSE: A randomized, open-label, phase III study of ruxolitinib in polycythemia vera (PV) patients resistant to or intolerant of hydroxyurea (HU).
    Verstovsek, Srdan
    Kiladjian, Jean-Jacques
    Sandor, Victor
    Lukawy, Jacek
    Li, Jingjin
    He, Shui
    Garrett, William M.
    Malek, Kamel
    Pirron, Ulrich
    Mookerjee, Bijoyesh
    Vannucchi, Alessandro M.
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [42] Markers of iron deficiency in patients with polycythemia vera receiving ruxolitinib or best available therapy
    Verstovsek, Srdan
    Harrison, Claire N.
    Kiladjian, Jean-Jacques
    Miller, Carole
    Naim, Ahmad B.
    Paranagama, Dilan C.
    Habr, Dany
    Vannucchi, Alessandro M.
    LEUKEMIA RESEARCH, 2017, 56 : 52 - 59
  • [43] Efficacy of Ruxolitinib By Baseline Spleen Volume in Patients with Polycythemia Vera Resistant to or Intolerant of Hydroxyurea
    Vannucchi, Alessandro M.
    Verstovsek, Srdan
    Jones, Mark M.
    He, Shui
    Li, Jingjin
    Habr, Dany
    Kiladjian, Jean-Jacques
    BLOOD, 2014, 124 (21)
  • [44] STIMULATION OF ERYTHROPOIESIS IN MICE BY SERA FROM PATIENTS WITH POLYCYTHEMIA VERA (PV)
    ZANJANI, ED
    GIDARI, AS
    ZALUSKY, R
    ROSS, J
    OSSIAS, AL
    WASSERMA.LR
    BLOOD-THE JOURNAL OF HEMATOLOGY, 1971, 38 (06): : 827 - &
  • [45] RUXOLITINIB TREATMENT FOLLOWING INTERFERON IN PATIENTS WITH POLYCYTHEMIA VERA: AN ANALYSIS FROM THE RESPONSE TRIAL
    Kiladjian, J. J.
    Guglielmelli, P.
    Griesshammer, M.
    Masszi, T.
    Durrant, S.
    Passamonti, F.
    Jones, M. M.
    Zhen, H.
    Li, J.
    Gadbaw, B.
    Habr, D.
    Verstovsek, S.
    HAEMATOLOGICA, 2016, 101 : 563 - 564
  • [46] High PRV-1 mRNA expression, a diagnostic marker for polycythemia vera (PV).
    Ricksten, A
    Palmqvist, L
    Wasslavik, C
    Johansson, P
    Andreasson, B
    Safai-Kutti, S
    Kutti, J
    BLOOD, 2002, 100 (11) : 799A - 799A
  • [47] JAK2V617F complete molecular remission in polycythemia vera/essential thrombocythemia patients treated with ruxolitinib
    Pieri, Lisa
    Pancrazzi, Alessandro
    Pacilli, Annalisa
    Rabuzzi, Claudia
    Rotunno, Giada
    Fanelli, Tiziana
    Guglielmelli, Paola
    Fjerza, Rajmonda
    Paoli, Chiara
    Verstovsek, Srdan
    Vannucchi, Alessandro M.
    BLOOD, 2015, 125 (21) : 3352 - 3353
  • [48] RUXOLITINIB VS BEST AVAILABLE THERAPY IN PATIENTS WITH POLYCYTHEMIA VERA TREATED IN THE RESPONSE STUDY: A SUBGROUP ANALYSIS OF HYDROXYUREA- AND NON-HYDROXYUREA-TREATED PATIENTS
    Passamonti, F.
    Harrison, C. N.
    Pane, F.
    Zachee, P.
    Kiladjian, J. -J.
    Vannucchi, A. M.
    Jones, M. M.
    He, S.
    Li, J.
    Khan, M.
    Habr, D.
    Verstovsek, S.
    HAEMATOLOGICA, 2015, 100 : 534 - 534
  • [49] Characteristics and Clinical Outcomes in Patients (Pts) With Polycythemia Vera (PV) Receiving Ruxolitinib (RUX) After Hydroxyurea HU): A Longitudinal Analysis From REVEAL
    Gerds, Aaron T.
    Grunwald, Michael R.
    Oh, Stephen T.
    Braunstein, Evan
    Xue, Zhenyi
    Bhatt, Valkal
    Yu, Jingbo
    Mesa, Ruben
    BLOOD, 2022, 140 : 6810 - 6812
  • [50] Morphological and Clinical Findings in Progressive Polycythemia Vera: Definition of Post-PV MF and Correlation to Treatment Resistance
    Kvasnicka, Hans Michael
    Frank, Gina Liviana
    Thiele, Juergen
    LABORATORY INVESTIGATION, 2017, 97 : 358A - 358A
12345